About 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide
2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide (PubChem CID 169421466) has the molecular formula C15H17N7O
and a molecular weight of 311.35 g/mol. Its IUPAC name is 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide.
Analyze 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide?
The IUPAC name of 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide (CID 169421466) is 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide.
What is the SMILES notation for 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide?
The canonical SMILES for 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide is CC(C)n1nccc1-c1nc(CC(N)=O)nn1-c1cccnc1.
What is the InChIKey of 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide?
The InChIKey is GOMJGKLPMBHLOD-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H17N7O/c1-10(2)21-12(5-7-18-21)15-19-14(8-13(16)23)20-22(15)11-4-3-6-17-9-11/h3-7,9-10H,8H2,1-2H3,(H2,16,23).
What are the key properties of 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide?
2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide has a molecular weight of 311.35 g/mol, XLogP of 1.13, 5 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[5-(2-propan-2-ylpyrazol-3-yl)-1-pyridin-3-yl-1,2,4-triazol-3-yl]acetamide is sourced from PubChem (CID 169421466), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).